Accelerate your early phase clinical trial decisions
Learn how IQVIA is providing industry leading early phase design strategies and delivery that are customized for your molecule.
White Paper: Optimizing Early-Phase Clinical Trials for Rapid, Evidence-Based Decision Making
This White Paper analyzes the evolving landscape of early phase clinical trials, the uncertainties compelling investors to be cautious, and strategies to navigate these challenges for quicker treatment delivery to patients via seamless phase I/II and model-informed drug development. It covers advances in innovative trial methodologies—including adaptive and hybrid designs and MIDD approaches—empowering sponsors to make better-informed go/no-go decisions earlier while improving safety and efficiency.

Ready to take the next step?
Request a meeting with a sales team member.
Please select an option that describes how we can help you.
By selecting this box, I consent to receiving marketing communications and information about IQVIA's offering by email.

Copyright © 2026 IQVIA Holdings Inc. and its affiliates. All rights reserved. Privacy Statement

DO NOT SELL MY PERSONAL INFORMATION